Revolution Medicines, Inc. (NASDAQ:RVMD) has 378 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 598,898 | 7.19% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 1,056,792 | 6.75% | $0.00 |
| Paradigm Biocapital Advisors LP | 31 Dec, 2025 | 0 | 421,112 | 6.77% | $0.00 |
| Avoro Capital Advisors LLC | 31 Dec, 2025 | 0 | 4,340,000 | 0.00% | $0.00 |
| FARALLON CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 0 | -14,668,588 | -50.15% | $0.00 |
| Bellevue Group AG | 31 Dec, 2025 | 0 | -568,119 | -10.19% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -449,065 | -76.75% | $0.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 0 | 947,448 | 8.34% | $0.00 |
| T. Rowe Price Investment Management, Inc. | 31 Dec, 2025 | 0 | -1,281,685 | -26.80% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | -182,521 | -96.98% | $0.00 |
| BAKER BROS. ADVISORS LP | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Alphabet Inc. | 31 Dec, 2025 | 0 | -788,175 | -19.07% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 869 | 265.75% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | -813,706 | -8.65% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | 1,998,972 | 183.57% | $0.00 |
| Nextech Invest, Ltd. | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Woodline Partners LP | 31 Dec, 2025 | 0 | -414,988 | -14.23% | $0.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 0 | -2,825,797 | -28.80% | $0.00 |
| Lunate Capital Ltd | 31 Dec, 2025 | 0 | -2,196,200 | -50.00% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | -1,145,349 | -21.80% | $0.00 |